Walleye Capital LLC Aquestive Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.31 - $4.5 $54,384 - $105,943	-23,543 Reduced 46.68%	26,892 $69,000
Q1 2024 May 15, 2024	SELL	$2.01 - $6.09 $152,319 - $461,506	-75,781 Reduced 60.04%	50,435 $214,000
Q4 2023 Feb 14, 2024	SELL	$1.29 - $2.47 $37,889 - $72,548	-29,372 Reduced 18.88%	126,216 $254,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.24 $372,465 - $556,214	-248,310 Reduced 61.48%	155,588 $238,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $428,131 - $1.01 Million	403,898 New	403,898 $666,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $200M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.